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We have performed an analysis of a family with kidney-yang deﬁciency syndrome (KDS) in order to determine the structural
genomic variations through a novel approach designated as “copy number variants” (CNVs). Twelve KDS subjects and three
healthy spouses from this family were included in this study. Genomic DNA samples were genotyped utilizing an Aﬀymetrix 100K
single nucleotide polymorphism array, and CNVs were identiﬁed by Copy Number Algorithm (CNAT4.0, Aﬀymetrix). Our results
demonstrate that 447 deleted and 476 duplicated CNVs are shared among KDS subjects within the family. The homologus ratio
of deleted CNVs was as high as 99.78%. One-copy-duplicated CNVs display mid-range homology. For two copies of duplicated
CNVs (CNV4), a markedly heterologous ratio was observed. Therefore, with the important exception of CNV4, our data shows
that CNVs shared among KDS subjects display typical Mendelian inheritance. A total of 113 genes with established functions
were identiﬁed from the CNV ﬂanks; signiﬁcantly enriched genes surrounding CNVs may contribute to certain adaptive beneﬁt.
These genes could be classiﬁed into categories including: binding and transporter, cell cycle, signal transduction, biogenesis,
nerve development, metabolism regulation and immune response. They can also be included into three pathways, that is, signal
transduction, metabolic processes and immunological networks. Particularly, the results reported here are consistent with the
extensive impairments observed in KDS patients, involving the mass-energy-information-carrying network. In conclusion, this
article provides the ﬁrst set of CNVs from KDS patients that will facilitate our further understanding of the genetic basis of KDS
and will allow novel strategies for a rational therapy of this disease.
1.Introduction
In order to observe the architectural complexity and struc-
tural variations of the human genome, single nucleotide
polymorphism (SNP) platforms have recently become a
promising approach for both SNP and non-SNP variability
[1–3]. Non-SNP variations usually include copy number
variants (CNVs), loss of heterozygosity, inversions, inser-
tions, deletions and other complex rearrangements, most
of which can not be detected by DNA sequencing [2]. A
thorough understanding of the roles of structural genomic
variants, such as CNVs, is an important prerequisite to
unravel the intricate genetic basis of complex diseases. For
example, there is increasing evidence of how CNVs can
inﬂuence susceptibility to HIV infection [4], modulate drug
responses [5] and contribute to genomic microdeletion and
duplication syndromes [6]. Beside SNPs, CNVs are now
being recognized as another important indicator for inter-
individual diﬀerences [7]. CNVs can cause Mendelian or
sporadic traits, or be associated with complex diseases, by
mechanisms such as gene dosage, gene disruption, gene
fusion and position eﬀects [8]. Orozco and colleagues [9]
observed that gene expression was altered in genes ﬂanking
CNVs, suggesting that CNVs may contain regulatory ele-
ments for these nearby genes. Therefore, the contribution of
CNVs to genetic variation and the consequently impact of
diverse phenotypes resulting from the aﬀects of the CNVs to
complex diseases may be greater than previously estimated
[2, 7–10].
Syndromes deﬁned by traditional Chinese medicine
(TCM), such as kidney-yang deﬁciency syndrome (KDS),
share some genetic features with complex diseases and/or
disease susceptibility. TCM, by its sheer nature, is based
on the integrated insight of diverse syndromes, that is, the2 Evidence-Based Complementary and Alternative Medicine
simultaneous manifestation of pathological processes on a
macroscopic level and thus provides the holistic approach
which might counteract or balance the conventional bias of
conventional medicine [11–13]. While there has been signif-
icant research on the physiology of KDS, few studies have
been conducted on its genetic background, largely due to
the lagged development of appropriate methodology for the
extreme complexity of the genetic basis of TCM syndromes
[1, 14, 15]. In contrast, there have been several studies that
stronglysuggestthegeneticbasisofKDS.First,thekidneysin
TCM are viewed as the root of life activities and represent the
origin of our congenital or inherited foundation [1]. They
regulatereproductive,urinary,endocrine,skeletal,bloodand
central nervous functions while also storing primordial yin
and primordial yang (known as the inherited kidney yin and
yang). Therefore, a congenital deﬁciency is one of the critical
causes of KDS [1, 14–16]. Secondly, relevant studies have
shed light on the complex patterns of the transcriptomes of
KDS patients [14–16]. Finally, epidemiological and clinical
observations have indicated that the development of KDS
can be inﬂuenced by both genetic and environmental factors
[16].
In the present work, we hypothesize that CNVs represent
part of the complex genetic basis of KDS. Based on current
advances in genome-wide analysis methods (e.g., SNP arrays
and their successful application in the genetic exploration of
complex diseases), we propose that KDS involves structural
variationsofgenomesuchasCNVs[1].I nor dert opr o v eour
hypothesis, we recruited a typical KDS family and employed
SNP arrays to probe their DNA structural heterogeneity.
Our ﬁndings indicate that this approach may facilitate a
further understanding of the genetic basis of KDS and will
allow novel strategies for a rational therapy of this disease
[17–20].
2. Methods
2.1. Subjects. This work has been approved by the Ethics
Board, Chengdu University of TCM, and all participants
provided written informed consent to participate in exper-
iments. A middle-scale epidemiological investigation was
conducted for the collection of KDS subjects in Chengdu,
China, based on a 40-items scoring table for KDS diagnosis
[1, 14, 16]. The diagnostic system had been described
previously [16]. Subjects were identiﬁed as healthy individ-
uals (total score: ≤5 points) or KDS patients (total score:
≥12 points). In order to upgrade the validity of TCM
diagnosis and ascertain the KDS subjects, every participant
was diagnosed by ﬁve independent TCM physicians with
single-blind method, and this procedure was repeated for
three consecutive years (from 2003 through 2005), all on the
ﬁrst Saturday of December [14].
This article focuses on a typical KDS family, in which 17
KDS subjects were distributed across four generations. Most
membersofthisfamilyliveinsurroundingareasofChengdu,
China. Twelve available KDS patients were recruited for
the study. Three healthy spouses in the pedigree were also
recruited as a non-KDS control group (Figure 1). The living
environment, life styles and ages of these non-KDS spouses
were best matched with that of the KDS subjects [14].
2.2. Isolation and Puriﬁcation of Genomic DNA Samples.
Samples of genomic DNA from all participants were iso-
lated and puriﬁed under a standard protocol [1]. Brieﬂy
stated, 3ml of blood was collected from each partici-
pant. Following this, the genome DNA was extracted by
conventional phenol/chloroform method, puriﬁed by 24:1
chloroform:isoamyl alcohol and 95% ethanol, re-suspended
in TE buﬀer, and stored at −80◦C prior to its usage.
2.3. Genotyping, Data Formatting and Quality Control.
Genomic DNA samples were genotyped in a commercial
laboratory (National Engineering Center for Biochip at
Shanghai, China), utilizing the Aﬀymetrix 100K array
(http://www.aﬀymetrix.com/) according to the manufac-
turer’s instructions. Brieﬂy, SNP genotyping was performed
with the HindIII array of the Aﬀymetrix GeneChip Mapping
100K set. The arrays were hybridized, washed and scanned
as per the manufacturer’s instructions. Genotype data of the
individual family members was generated using GeneChip
DNA Analysis Software (GDAS, Aﬀymetrix). The pedigree
information, allele frequencies and map position of the SNPs
were combined with the genotype data generated by GDAS
[1].
2.4. Analysis of CNVs. We employed a software, Copy
Number Algorithm (CNAT4.0, Aﬀymetrix), for obtaining
the shared CNVs among KDS subjects from the KDS family.
This software is especially useful for the SNP analysis of
complex diseases [14, 17–20]. The data-mining procedure
was performed with the following steps:
(1) Probe-level and SNP-level ﬁltering.
(2) Probe-level normalization of signal intensity.
(3) Allele-speciﬁc summarization for each SNP.
(4) Global reference generation for unpaired experi-
ments.
(5) Raw copy number estimation.
(6) Linear regression on the raw copy number estimate
to correct for artifacts introduced by the polymerase
chain reaction (PCR) fragmentation process.
(7) PCR normalized copy number data—Gaussian
smoothed for enhancement of the signal-to-noise
ratio (SNR). All data based on the PCR results with
ap ri m e r( 5   ATTATGAGCACGACAGACGCCTGA-
TCT 3 ) were automatically normalized by method
of Gaussian smoothed Log2 ratio value for the allele
with the higher signal intensity.
(8) Hidden Markov model (HMM)-based segmentation
to obtain the diﬀerent CNV state partitions and
median log2 ratio value of all the contiguous SNPs
in the given HMM copy number state segment of the
allele with the higher signal intensity.Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Pedigree tree of the collected KDS family.
The parameters used for CNV designation required that
fourSNPsonthreerestrictionfragmentsgaverisetoasignal-
intensity ratio >1.12 for insertions or >0.89 for deletions.
CNVs were considered signiﬁcant for P-values <.01 using
5000 permutations of the data. For data integration, only
CNVs identiﬁed in at least 10% of the comparisons to the
diploid samples were retained [20].
2.5. Mining the Genes Located in the Flanks of CNVs. Genes
located within 100bp of the CNVs’ ﬂanks [8, 20]w e r e
checked via an authoritative Web tool, GeneView (http://
www.ncbi.nlm.nih.gov/SNP/). Their biological functions
and related pathways were then annoted by FatiGO (http://
fatigo.bioinfo.ochoa.ﬁb/es) and KEGG (http://www.kegg.jp/
kegg/pathway.html), respectively.
3. Results
3.1.ARepresentativeKDSFamilyCollectedbyTCMDiagnosis.
We collected a typical KDS pedigree, including 17 KDS sub-
jects who live around Chengdu, China. Twelve available KDS
patients and three healthy spouses (as non-KDS control) of
theparticularpedigreewerecollectedfortheidentiﬁcationof
CNVs. Our selection criteria indicated that almost all of the
scores marked by ﬁve physicians tallied with each other, and
scores marked from 2003 through 2005 for every participant
were reproducible [1, 14], indicating the reliability of the
classiﬁcation of the recruited subjects and the validity of the
employed TCM criteria. Hence, these samples were utilized
for identifying CNVs related to KDS (Figure 1).
3.2. Identiﬁcation of Shared CNVs among KDS Subjects.
Results of SNP arrays revealed thousands of CNVs from
KDS patients. Among them, 447 of deleted and 476 of
duplicated CNVs are shared among all KDS subjects within
the family analyzed in this study. These CNVs are not equally
distributed among chromosomes (Figure 2). CNVs that
totallydeleted(CNV0)aremostlylocatedonchromosomeX.
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Figure 2: The chromosome distribution of shared CNVs among
KDS patients.
One-copy-deleted CNVs (CNV1) are frequently distributed
on chromosomes 2, 4, 6–8 and 14, and a few were observed
on chromosomes 9, 16–22 and X. CNVs such as one-copy-
duplicated CNV3 are frequently located on chromosomes 4,
5 and 10. Tetraplont CNVs (CNV4) are principally observed
on chromosomes 9, 11 and 19.
These CNVs were then analyzed for Mendelian inheri-
tance. Our results indicated that only one of the 447 deleted
CNVswasnotconsistentwiththoseofotherfamilymembers
(Table 1).ThehomologousratioofdeletedCNVswasashigh
as 99.78%; thus indicating that the deleted CNVs are clearly
inherited in this KDS family. In contrast, the duplicated
CNVs (i.e., gain of one or two copies) display a much lower
homologous ratio (62.61%).
3.3. Functional Annotation of Genes Located within the Flanks
of Shared CNVs. A total of 113 genes with established
functions were identiﬁed from the ﬂanks of shared CNVs.
Of these, 41 genes were derived from the deleted CNVs,4 Evidence-Based Complementary and Alternative Medicine
Table 1: Statistic results of homologus and heterologous CNVs
from a KDS family.
Copy
number(s)
Number of
homologous
CNVs (%)
Number of
heterologous
CNVs (%)
CNV=0 12 (100) 0 (0)
CNV=1 433 (99.77) 1 (0.23)
CNV=3 278 (76.58) 85 (23.42)
CNV=4 20 (17.70) 93 (82.30)
and can be subtyped into ﬁve functional classes: binding
and transporter, cell cycle, cell adhesion, signal transduction
and immune-response genes. The 72 genes derived from
duplicatedCNVscanbeclassiﬁedintoﬁvefunctionalgroups:
binding and transporter, nervous system development,
metabolism regulation, biogenesis and immune-response
genes (Table 2).
Pathways related to the genes located in the CNV ﬂanks
can largely be classiﬁed into three groups: signal transduc-
tion pathways, immune-response pathways and metabolic
processes. The mitogen-activated protein kinase (MAPK)
pathway, transmembrane receptor protein tyrosine kinase
signaling pathways and neuropeptide signaling pathways all
belong to signal-transduction pathways and these pathways
are concordant with the relevant results of the transcriptome
analysis of KDS [14]. Pathways such as Fc epsilon RI
signaling, cytokine-cytokine receptor interactions, T cell
receptor signaling pathways, and antigen processing and
presentation are major immune-response pathways. Other
pathways are largely involved in metabolic processes and
energy metabolism (Table 3).
4. Discussion
Our results are consistent with previous studies indi-
cating that CNVs are highly inheritable [8, 17–20]. We
used an established platform to identify CNVs which has
been extensively utilized for identiﬁcation of both linkage-
disequilibrium SNPs and CNVs [17–20]. Totally there are
923 CNVs shared among KDS subjects from a single
family. The high homologous ratio of deleted CNVs suggests
a typical Mendelian inheritance within the KDS family.
Similarly, the one-copy-duplicated CNVs show moderate
Mendelian inheritance. Thus, we conclude that the majority
ofCNVsinKDSoﬀspringareinherited,conﬁrmingprevious
reports that CNVs are highly inheritable [21–24]. Thus,
our work displays a clear Mendelian pattern of inheritance
for KDS, a TCM syndrome that shares many features with
complex diseases [1, 14, 16]. This result and relevant studies
by other groups indicate that many larger scale variations,
such as CNVs, may represent a major genetic component
of phenotypic diversity [25–30]. Therefore, CNVs should
be considered another kind of relevant markers for use in
the genetic exploration of complex diseases as well as TCM
syndromes.
In contrast to the strong correlation of speciﬁc CNVs
with inheritance, a signiﬁcant diﬀerence was found with
two-copy-duplicated CNVs (CNV4) as these CNVs show
Mendelian inconsistency rather than inheritance. Among
the 113 CNV4 derived from this KDS family, 93 were
heterologous, implying that 82.30% of these CNV4 were new
mutations. However, the exact mechanisms of individual
mutations and the consequences of these mutations on the
disease process are not understood. Theoretically, CNV4
should be less stable than those of other CNVs [29–31].
Consequently, from an evolutionary standpoint, the low
degree of CNV4 inheritance might reinforce the concept of
chromosome stability in this disease phenotype. Indeed, the
functional impact of most CNVs remains poorly character-
ized[32,33]andourcurrentknowledgeregardingCNVsand
their heritability is still rudimentary, due to their location in
regions of complex genomic structure and to the technical
limitations of association studies [34, 35]. Taken together,
with the important exception of CNV4, our data suggest that
CNVs shared among KDS patients display typical Mendelian
inheritance.
CNVs canintensivelyimpacttheactivityofnearbygenes.
Orozco et al. [9] observed that gene expression was altered
in genes ﬂanking CNVs; suggesting that CNVs may contain
regulatory elements for these genes, and may play a role
in the mechanisms underlying speciﬁc metabolic traits in
mice. Our results identiﬁed a signiﬁcant overabundance of
genes in the ﬂanking region of CNVs which are shared
among KDS subjects. A total of 113 genes with established
functions were identiﬁed within 100bp of the CNV ﬂanks,
representing12.24%oftheCNVs(113/923).Consideringthe
factthat<1%ofthesequenceofhumangenomeiscomposed
of genes, our data show the ﬁrst set of markedly enriched
protein-coding genes in the CNV ﬂanks [23]. The excess
overabundance of genes surrounding CNVs may be due to
an adaptive beneﬁt of increased gene dosage, particularly in
those genes involved in ﬁghting infection and sensing the
environment [21–24].
Bioinformatic analysis show that genes located in the
ﬂanks of CNVs of KDS patients can be classiﬁed into a small
number of classes. Genes related to deleted CNVs largely
belong to binding and transporters, the cell cycle, signal
transduction and the immune response, whereas genes asso-
ciatedwithduplicatedCNVs,canbecategorizedintobinding
and transporters, biogenesis, nervous system development,
metabolism regulation and the immune response. Therefore,
these ﬁndings indicate that many vital physiological func-
tions, such as metabolism, biogenesis, development, signal
transduction and the immune response are ubiquitously
attenuated or disrupted in KDS patients.
IntheTCMoverview,thekidneyisinchargeofvitalbody
functions and its role is broader than just the anatomical
kidney [16]. It performs reproductive, urinary, endocrine,
skeletal, blood and central nervous functions while also
storing primordial yin and yang. Hence, the TCM Kidney is
the most important system of the body. It is the root of life
activities, warms and promotes the functions of other organs
and is the origin of our congenital (inherited) foundation
[1, 11, 16]. Since the TCM kidney aﬀects so many vital func-
tions, KDS patients present with a wide range of symptoms,
including: sore and/or pain in the lower back, cold and weakEvidence-Based Complementary and Alternative Medicine 5
Table 2: Genes mined within 100bp of the CNVs of a KDS family.
CNV types Functional class Representative genes
Deleted CNVs Binding and transporters
ZNF509, RNF150, DMRTC2, MYRIP, DDX26B, ZNF509, DMRTC2, ZNF509,
MYRIP, FRMD4A, SCHIP1, DNAJC18, SDK1, CDH17, RP13-102H20.1,
SLC5A9, MYRIP, ENTHD1
Cell cycle NEK7, PPP1R1C, MID1, FAM162A, RFC3, CTAGE5, RHOJ, CDC73,
EIF4G3, CDKL1
signal transduction SDK1, LPHN3, FNDC3B, HAND2,MDGA1, MATR3, DST, MDGA1,
CRADD, ARHGEF1, PKIB, NRG1, PIK3AP, ARHGAP25, GRAP2
Immune response C4orf7, CSN3, PROL1, GPX3, C1RL, GRAP2
Enlarged CNVs Binding and transporters
ROR1, ERCC6, ALKBH8, C1orf83, KIAA0999, TUBA8, SLC28A2,
LOC401898, KIAA2022, ZNF331, ZNF487, C1orf83, ELAC2, PCDH9,
DNAJC3, LRRC50, ZNF208, LOC401898, LOC730087, ELAC2, CRB1, FSTL5,
CDH19, TRPM3, TMTC1, SYT1, FSTL5, CPLX4, CDH19, DIAPH3,
ERGIC2,LOC348751, COG2, SLC28A2
Nervous development ROR1, SEMA5A, SEMA5B, OPRM1, DYM, CNTN5, NTRK3, VIPR2, PCDH9
Metabolism regulation AHCYL1, PTTG2, PRIM2, HPGD, HPSE2, ALKBH8, PNLIPRP3, MBTPS1
Biogenesis SPATA5L1, ODF2, FMN1, SPTLC1, TBC1D1, HNT, MATN2, DGFC,
GREM1, BMP
Immune response NTRK3, GPR177, ASTN2, CNTN5, GAB2, ELMOD1, DNAJC3, FER,
HLA-DQB1
Table 3: Pathways derived from the genes located in the CNV ﬂanks of a KDS family.
CNVs Copy
numbers Related genes Related pathways
rs2002594; rs1986617 1 FAM162A Mitochondrial apoptotic cascades
rs10517547; rs10517548; rs2122642;
rs2345041; rs1823535; rs1823536; rs1470724 1 LPHN3 G-protein-coupled-receptor proteolysis
rs764223 1 PGAM1 Glycolysis/gluconeogenesis; metabolism of
carbohydrates
rs137964; rs10483201 1 GRAP2 T cell receptor signaling pathway
rs10491333 4 HLA-DQB1 Antigen processing and presentation
rs2895201 4 SPTLC1 Sphingolipid metabolism
rs1988981; rs1321555; rs1358815; rs1964875; 4 PRIM2 Purine and pyrimidine metabolism; telomere
maintenance
rs3797819; rs10515399; rs1896582; rs1366081;
rs9326759 4 FER Adherens junction
rs342597; rs10507638; rs10507639 3 DIAPH3 Regulation of actin cytoskeleton
rs10520675; rs10520671; rs7167737;
rs1948066; rs10520673; rs965313 3 NTRK3 MAPK pathway
rs6816712; rs2911940; rs10517654;
rs10517655; rs7662187; rs10517658 3P D G F C Cytokine-cytokine receptor interaction; Focal adhesion;
Gap junction
rs855858; rs855860; rs10489736 3 ROR1 transmembrane receptor protein tyrosine kinase
signaling pathway
rs2912 3 GAB2 Fc epsilon RI signaling pathway
rs10491050; rs7092874; rs7904118 3 SORCS1 neuropeptide signaling pathway
rs10485060; rs9322451; rs1852629 3 OPRM1 Neuroactive ligand-receptor interaction
rs1060447; rs4919231; rs1932796; rs716838;
rs2169462; rs10509722 3 HPSE2 Glycosaminoglycan degradation
limbs, water retention in the legs, copious and pale urine,
aversion to cold, poor appetite, spiritual fatigue, depression,
sexual dysfunction, premature ejaculation, adrenal fatigue,
hypothyroidism and a weak pulse. In short, Kidney yang
is the pilot light for our energy system; and the diming of
this light represents KDS and consequently results in the
insuﬃcient function of the reproductive, urinary, endocrine,
skeletal and nervous systems.
Our results indicate that CNVs derived from KDS
subjects are enriched in genes that are consistent with KDS6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: A hypothetical diagram demonstrating the relationships between KDS patients and CNVs.
symptoms. Based on the results presented here, we oﬀer
the following conclusions. First, KDS patients show an
extensively attenuated ability to resist infection and to adapt
to their environment, in accordance with the TCM theory
that “Kidney yang prevents evils or pathogens from invading
the body” [14, 16]. More importantly, ﬁrstly, Kidney yang
works closely with the neural-endocrine-immune network
thus connecting the immune response to the environment.
Second, KDS patients demonstrate the potential for altered
gene expression in those genes involved in the cell cycle,
biogenesis and nervous system development, aligning with
the TCM concept that “the kidney is the regulator of growth
and development”. Third, genes involved in metabolism
regulation are overrepresented in the CNV ﬂanks of KDS
subjects, a ﬁnding in agreement with another TCM principle
that “Kidney yang motivates the power of human vitality,
and controls the storage of vital essence”. In view of these
identiﬁed CNVs, many vital body activities of KDS patients
might be attenuated or disrupted. In brief, the results of our
CNV analysis provide a basis for the systemic disorders of
KDS patients.
It is established that pedigree is the most classical
approach applied in human genetics studies in conventional
medicine. However, few studies have been performed on
the exploration of genetic traits of TCM syndromes by the
pedigree approach. In this study, we recruited a typical KDS
familyofHanChinese,comparedthediﬀerentSNPsbetween
12 KDS and three Non-KDS spouses within the family and
identiﬁed 923 CNVs shared among the KDS subjects.
This design of CNV research has also been successfully
employed in previous publications from other laboratories.
For instance, Yang et al. [17] genotyped 46 individuals in a
three-generation pedigree with 19 aﬀected and 27 unaﬀected
subjects, and identiﬁed 50 CNV regions. Therefore, we
conclude that the pedigree approach is reasonable and
suitable for genetic studies of TCM syndromes.
The main limitation of this work is that only one KDS
family was screened for the presence of CNVs. Theoretically,
the ultimate proof of the involvement of CNVs in TCM syn-
dromes will require large-scale studies of multiple families.
Therefore, the limitation of this report can be overcome by
introducingasimilardesignofotherKDSpedigreesandKDS
patients collected via a randomized method of identiﬁcation.
In conclusion, this article reports the ﬁrst set of CNVs
involvedinKDS,oneoftheprincipleTCMsyndromes.These
CNVs display a clear Mendelian inheritance. Genes located
in CNV ﬂanks are signiﬁcantly enriched and generally
consistent with key symptoms of KDS patients. These CNVs
would greatly beneﬁt the genetic and functional analysis
of KDS. Hence, we propose a hypothetical diagram that
demonstrates the relationships between KDS patients and
their CNVs (Figure 3). Our data will contribute to a further
understanding of the genetic basis of the KDS and will allow
novel strategies for a rational therapy of this disease.
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